How 0.55T MRI Redefines Lung Care in Sarcoidosis Patients

Currently, advancements in pulmonary imaging highlight the clinical utility of low-field lung MRI as a radiation-free diagnostic modality. Specifically, clinicians face challenges when monitoring interstitial lung disease in sarcoidosis patients due to repeated radiation exposure. Consequently, a team of researchers investigated the feasibility of contemporary 0.55-Tesla (0.55T) scanners to resolve this problem.

A Radiation-Free Breakthrough in Pulmonary Assessment

Typically, high-resolution computed tomography serves as the traditional gold standard for assessing lung morphology. However, this method exposes patients to cumulative radiation over time. Therefore, low-field lung MRI represents a promising alternative. In addition, this technology reduces magnetic susceptibility artifacts that usually compromise higher-field scanners. Consequently, it delivers clear morphological and functional metrics of the lungs without any radiation.

Functional and Morphological Insights Using Low-field Lung MRI

Specifically, to evaluate this modality, a prospective study compared 15 sarcoidosis patients against 30 healthy volunteers. Specifically, the researchers combined bSTAR morphology sequences with matrix-pencil based functional proton MRI. As a result, the functional maps successfully quantified ventilation and perfusion defect percentages. Furthermore, the patients demonstrated significantly higher functional defects than the healthy cohort. Thus, these biomarkers effectively track regional respiratory impairment.

Diagnostic Performance and Clinical Implications

In comparison, 0.55T MRI achieved its highest sensitivity for consolidations. Specifically, readers recorded an 86% sensitivity rate for these findings. However, the system showed moderate performance for nodules and ground-glass opacities. Furthermore, it demonstrated lower sensitivity for reticulations and traction bronchiectases. Therefore, computed tomography remains necessary for fine structural detail, while MRI serves as an excellent monitoring tool. Consequently, clinicians can adopt this technology to reduce lifetime radiation doses for chronic patients.

Frequently Asked Questions

Q1: What are the main clinical benefits of using low-field lung MRI for sarcoidosis?

Indeed, low-field lung MRI provides a radiation-free method to assess both lung structure and function. Specifically, it allows clinicians to monitor chronic sarcoidosis patients safely over time without cumulative radiation exposure.

Q2: How does the imaging performance of 0.55T MRI compare with traditional CT scans?

For instance, the 0.55T MRI shows high sensitivity for consolidations and moderate sensitivity for ground-glass opacities. However, computed tomography remains superior for detecting fine structures like reticulations and traction bronchiectases.

References

1. Pradella M et al. Feasibility of lung imaging at 0.55T for assessment of interstitial lung disease in patients with pulmonary sarcoidosis. Eur Radiol. 2026 Jun 27. doi: 10.1007/s00330-026-12708-z. PMID: 42362795.
2. Bayerl N, Mathy CS, Bergmann C, et al. Contemporary 0.55 T MRI to visualize interstitial lung disease – An exploratory study. Eur J Radiol. 2026 Jan 5;100720. doi: 10.1016/j.ejro.2025.100720. PMID: 41550670.
3. Schonour RB, Tang F, Bowers K, et al. Determinants of image quality in respiratory triggered free breathing lung MRI at 0.55 T in adults. Radiology Advances. 2026 Jan 13;3(1).